banner

Wall Street Falters Again on Tuesday

Dow Jones November 13 2012

Wall Street was lower again on Tuesday while traders fretted over a delay in organizing a crucial installment of bailout money for Greece and the approaching “fiscal cliff” in the United States.

The Dow Jones Industrials dumped 58.90 points to finish the session at 12,756.20.

The S&P 500 staggered 5.50 points to 1,374.53, and the Nasdaq Composite Index withered 20.37 points to 2,883.89.

Lawmakers are trying to strike a deal that prevents the onset of sharp spending cuts and tax increases in January. President Obama plans to meet with union leaders on Tuesday, a number of business leaders on Wednesday and then Congressional leaders on Friday.

Windows chief Steven Sinofsky, heir apparent to Microsoft CEO Steve Ballmer, left the company late Monday. Sinofsky had been at Microsoft since 1989, trusted with overseeing many of the company’s core products — including Office and the recent Windows 8 debut.

Shares of Dow component Home Depot rose after the company beat sales and earnings forecasts. The nation’s largest homebuilding supply retailer raised its guidance for the current quarter, and said it’s seeing a beginning in the “healing of the housing market.”

Dick’s Sporting Goods beat analyst expectations on both income and revenue and raised its guidance for fourth-quarter sales. Michael Kors Holdings reported quarterly earnings and revenue that beat expectations.



Meanwhile, Monster Beverage shares were up 2% after the company announced plans to repurchase up to $250 million U.S. worth of its own common stock.

Saks reported earnings in line with forecasts but fell short on revenue. The retailer lowered its sales guidance for the fourth quarter, citing disruptions from Hurricane Sandy.

Shares of TJX rose after the parent of T.J. Maxx and Marshalls reported that third-quarter sales and earnings rose.

After the bell, Cisco Systems will release its results.

Economically speaking, the Treasury Department reported a larger-than-expected deficit of $119.9 billion U.S. for October, compared with an expected shortfall of $113 billion U.S.

The price on the benchmark 10-year U.S. Treasury gained ground early Tuesday, lowering yields to 1.59% from Friday’s 1.61%. Treasury prices and yields move in opposite directions.

Oil prices surrendered 30 cents to $85.31 U.S. a barrel.

Gold prices dropped $5.90 an ounce to $1,725.20 U.S.

Dow Jones Industrial Average (DJIA) Stock Quote and News:







Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial

Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial(0)

Blue Calypso Inc. (OTCBB: BCYP), an innovator in digital social advertising, mobile content syndication, and analytics, recently announced a Markman hearing set for August 27, 2013 in its patent infringement case against LivingSocial. Findings from this hearing may encourage settlements or provide insight into the likelihood of a particular outcome. With the success seen by

Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen

Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen(0)

One might think that celebrity endorsements would be fantastic for the share price of a small or microcap company. After all, famous and successful athletes or movie stars have a stack of cash to invest and the connections to help accelerate business developments. Oddly, though, it doesn’t seem to have a great deal of impact.

Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract

Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract(0)

Shares of Sunvalley Solar, Inc. (OTCBB: SSOL) are rising in trading Monday morning after the solar power technology company disclosed a new contract to 87.5-kilowatt solar system installation contract from Corporate Logistics in City of Industry, California. The contract is for a system capable of generating 131,146 kilowatt hours of electrical power each year, utilizing

Men’s Health Features Naked Brand Group Line of Underwear

Men’s Health Features Naked Brand Group Line of Underwear(0)

Naked Brand Group, Inc. (OTCQB: NAKD) said Friday that its Naked Boxer Brief has been selected by Men’s Health for its online guide, “Affordable Spring Style Guide 100 under $100.”  The guide was published on MensHealth.com on March 20.  This is the second time the company has been featured in the men’s mag in as

Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials

Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials(0)

Sunshine Biopharma Inc. (OTCQB: SBFM) reported on Thursday that it is in negotiations with Contract Manufacturing Organizations, or CMOs, as the next progression towards the anticipated clinical trials of its flagship cancer drug, Adva-27a, against multi-drug resistant forms of breast cancer. The trials are scheduled to be hosted by the leading cancer center Jewish General

read more
banner


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.